Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

2014 ◽  
Vol 13 (10) ◽  
pp. 987-996 ◽  
Author(s):  
Thomas Voit ◽  
Haluk Topaloglu ◽  
Volker Straub ◽  
Francesco Muntoni ◽  
Nicolas Deconinck ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Phase 2 ◽  
Safety And Efficacy ◽  
Phase 2 Study

G.P.3.05 Phase 2 study of PTC124 for nonsense mutation suppression therapy of Duchenne muscular dystrophy (DMD)

2007 ◽  
Vol 17 (9-10) ◽  
pp. 783 ◽  
Author(s):  
C. Bönnemann ◽  
R. Finkel ◽  
B. Wong ◽  
K. Flanigan ◽  
J. Sampson ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Nonsense Mutation ◽  
Phase 2 ◽  
Phase 2 Study

scholarly journals Safety and Efficacy of Gevokizumab in Patients with Behçet’s Disease Uveitis: Results of an Exploratory Phase 2 Study

2016 ◽  
Vol 25 (1) ◽  
pp. 62-70 ◽  
Author(s):  
Ilknur Tugal-Tutkun ◽  
Sibel Kadayifcilar ◽  
Moncef Khairallah ◽  
Sung Chul Lee ◽  
Pinar Ozdal ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Phase 2 ◽  
Safety And Efficacy ◽  
Behcet's Disease ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document